Table B.1.
Chemical name FL‐no JECFA‐no | End‐point | Test system | Concentration | Results | Reference | Comments |
---|---|---|---|---|---|---|
Benzophenone 07.032 831 |
SOS/umuC assay | S. Typhimurium TA1535 | 0–1,000 μMa | Positive | Takemoto et al. (2002) | Study is reliable. Positive at the higher concentrations (100–1,000 μM) in the presence of metabolic activation. However, the relevance of this endpoint is low |
7.8–1,000 μg/mLa | Positive | Kotnik et al. (2016) | Study is reliable. Positive at the highest concentration in the presence of metabolic activation. However, the relevance of this endpoint is low | |||
Bacterial reverse mutation assay | S. Typhimurium TA98, TA100, TA1535, TA1537 | 10–2,000 μg/platea,d | Negative | CCRIS (2009) | Reliability cannot be evaluated (full study report not available) | |
3–333 μg/plateb,e | Negative | |||||
10–1,000 μg/plateb,e | Negative | |||||
1–166 μg/platec,e | Negative | |||||
Gene mutation in mammalian cells | L5178Y (tk+/−) mouse lymphoma cells |
33–90 μg/mLc 35–145 μg/mLb |
Negative | |||
8.9–142.8 μg/mLc 8.9–141.7 μg/mLb |
Negative | Jeon et al. (2007) |
Reliable with limitations (experimental details are not provided) 80% inhibitory concentration (IC80) was used as maximum concentration |
With and without metabolic activation.
With metabolic activation.
Without metabolic activation.
Plate‐incorporation.
Pre‐incubation.